FDA Approved: POSACONAZOLE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved Hikma Pharmaceuticals USA Inc.'s supplemental application for posaconazole (POSACONAZOLE), approving the generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candidiasis
• Invasive Aspergillosis
• Invasive Fungal Infections
• Oropharyngeal Candidiasis

Drugs mentioned

• POSACONAZOLE (POSACONAZOLE)

Snippet

SUPPL AP for POSACONAZOLE (POSACONAZOLE)